Vasotop contains the ACE inhibitor ramipril.
Vasotop 1.25: beige, oblong tablets half scored on one side.
Vasotop 2.5: yellow, oblong tablets half scored on one side.
Vasotop 5: light pink, oblong tablets half scored on one side.
Vasotop 1.25 - each tablet contains 1.25 mg ramipril.
Vasotop 2.5 - each tablet contains 2.5 mg ramipril
Vasotop 5 - each tablet contains 5 mg ramipril.
Indications for use
Vasotop is indicated for the treatment of congestive heart failure (NYHA: decompensation grades II-IV). The product can be used in combination with diuretics, and the cardiac glycosides digoxin or methyl-digoxin.
Each strength is supplied in an outer carton containing 28 oblong flavoured scored tablets.
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018